Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Arrowhead Pharma (ARWR)

Arrowhead Pharma (ARWR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,566,315
  • Shares Outstanding, K 102,292
  • Annual Sales, $ 168,800 K
  • Annual Income, $ 67,970 K
  • 60-Month Beta 1.67
  • Price/Sales 26.54
  • Price/Cash Flow 56.51
  • Price/Book 9.10

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.06
  • Number of Estimates 7
  • High Estimate 0.67
  • Low Estimate -0.34
  • Prior Year 0.11
  • Growth Rate Est. (year over year) -154.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.86 +34.84%
on 09/11/20
53.12 -16.59%
on 09/16/20
+1.45 (+3.38%)
since 08/24/20
3-Month
32.86 +34.84%
on 09/11/20
53.12 -16.59%
on 09/16/20
+4.55 (+11.44%)
since 06/24/20
52-Week
19.51 +127.11%
on 03/18/20
73.72 -39.89%
on 11/29/19
+16.23 (+57.80%)
since 09/24/19

Most Recent Stories

More News
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that as an inducement to entering into employment with the Company, on September 11, 2020, the Compensation Committee of the Board of Directors...

ARWR : 44.31 (-0.74%)
Biotech Stock Roundup: Bristol-Myers' Updates, VCNX's Disappointing Data & More

The biotech sector remains in focus with regulatory and other pipeline updates.

BMY : 58.25 (-1.25%)
SGEN : 179.43 (+0.09%)
BLUE : 55.67 (-0.50%)
ARWR : 44.31 (-0.74%)
BPMC : 88.24 (-1.56%)
VCNX : 1.8100 (-2.69%)
SmarTrend Watching for Potential Pullback in Shares of Arrowhead Pharma After 47.13% Gain

Arrowhead Pharma (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $40.08 to a high of $53.11. Yesterday, the shares gained 47.1%, which took the trading range above the 3-day high...

ARWR : 44.31 (-0.74%)
Arrowhead ARO-AAT Phase 2 Interim Results in Patients with Alpha-1 Liver Disease Demonstrate Improvements in Key Parameters after Six Months of Treatment

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced positive interim 24-week liver biopsy results in four subjects from AROAAT2002, an open-label Phase 2 clinical study of ARO-AAT, the company's...

ARWR : 44.31 (-0.74%)
19.3% Return Seen to Date on SmarTrend Arrowhead Pharma Call (ARWR)

SmarTrend identified a Downtrend for Arrowhead Pharma (NASDAQ:ARWR) on August 6th, 2020 at $42.20. In approximately 1 month, Arrowhead Pharma has returned 19.34% as of today's recent price of $34.04.

ARWR : 44.31 (-0.74%)
Arrowhead Pharmaceuticals Appoints Oye Olukotun to Board of Directors

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that the board of directors appointed veteran pharmaceutical industry executive Oye Olukotun, M.D., MPH, as an independent director of the...

ARWR : 44.31 (-0.74%)
Arrowhead Pharmaceuticals to Participate in Upcoming September 2020 Conferences

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events:

ARWR : 44.31 (-0.74%)
Arrowhead Presents Positive New Phase 1/2 Clinical Data on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3 at European Society of Cardiology Congress 2020

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced the presentation of positive new Phase 1/2 clinical data on two RNAi-based cardiometabolic candidates, ARO-APOC3 targeting apolipoprotein C-III...

ARWR : 44.31 (-0.74%)
Arrowhead and Collaborator Janssen Present Phase 2 Clinical Data on Investigational Hepatitis B Therapeutic JNJ-3989 at The Digital Liver Congress

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced the presentation of Phase 2 clinical data from the AROHBV1001 phase 1/2 study on a double combination of JNJ-3989 (formerly ARO-HBV) and a...

ARWR : 44.31 (-0.74%)
Arrowhead Pharmaceuticals to Participate in Upcoming August 2020 Conferences

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events:

ARWR : 44.31 (-0.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade ARWR with:

Business Summary

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes....

See More

Key Turning Points

2nd Resistance Point 47.08
1st Resistance Point 45.70
Last Price 44.31
1st Support Level 42.96
2nd Support Level 41.60

See More

52-Week High 73.72
Fibonacci 61.8% 53.01
Fibonacci 50% 46.62
Last Price 44.31
Fibonacci 38.2% 40.22
52-Week Low 19.51

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar